Towards uniformity in communication and a tailor-made treatment for displaced intra-articular calcaneal fractures.

摘要

Current issues and challenges with commercial bone devices may be resolved by using novel BMP6 biocompatible device OSTEOGROW, which will be clinically tested in metaphyseal bone fractures, compartments where BMP2 and BMP7 have not been effective.